FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for SAPHRIS (asenapine) to update its labeling, reflecting an expanded or clarified indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Saphris (asenapine)

Snippet

SUPPL AP for SAPHRIS (ASENAPINE MALEATE)